These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7861227)

  • 1. Human monoclonal antibody BT32/A6 and a cell cycle-independent glioma-associated surface antigen.
    Dan MD; Earley EM; Griffin MC; Maiti PK; Prashar AK; Yuan XY; Friesen AD; Kaplan HA
    J Neurosurg; 1995 Mar; 82(3):475-80. PubMed ID: 7861227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity of human MAb BT32/A6 with neuroepithelial tumors.
    Dan MD; Maiti PK; He X; Gillespie GY; Halliday WC; Prashar AK; Friesen AD; Kaplan HA
    J Neurooncol; 1997 Nov; 35(2):93-100. PubMed ID: 9266445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen related to cell proliferation in malignant gliomas recognized by a human monoclonal antibody.
    Kokunai T; Tamaki N; Matsumoto S
    J Neurosurg; 1990 Dec; 73(6):901-8. PubMed ID: 2230972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human antiglioma monoclonal antibodies from patients with astrocytic tumors.
    Dan MD; Schlachta CM; Guy J; McKenzie RG; Dorscheid DR; Sandor VA; Villemure JG; Price GB
    J Neurosurg; 1992 Apr; 76(4):660-9. PubMed ID: 1545260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
    Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
    Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma.
    Wakabayashi T; Yoshida J; Seo H; Kazo K; Murata Y; Matsui N; Kageyama N
    J Neurosurg; 1988 Mar; 68(3):449-55. PubMed ID: 3343615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis by fluorescence microscopy and flow cytometry of monoclonal antibodies produced against cell surface antigens.
    Bolaños B; Bodón Q; Jiménez T; García-Mayol D; Lavergne JA; Díaz AM
    P R Health Sci J; 1988 Apr; 7(1):35-8. PubMed ID: 3375422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of anti-idiotypic reagents in the EGFRvIII tumor-associated antigen system.
    Wikstrand CJ; Cole VR; Crotty LE; Sampson JH; Bigner DD
    Cancer Immunol Immunother; 2002 Feb; 50(12):639-52. PubMed ID: 11862416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of antigenic expression of human glioma cells.
    McKeever PE; Davenport RD; Shakui P
    Crit Rev Neurobiol; 1991; 6(2):119-47. PubMed ID: 1934088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas.
    Couldwell WT; Weiss MH; Law RE; Hinton DR
    J Neurosurg; 1995 Mar; 82(3):461-8. PubMed ID: 7861225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines.
    Colombatti M; Dipasquale B; Del-l'Arciprete L; Gerosa M; Tridente G
    J Neurosurg; 1989 Sep; 71(3):388-97. PubMed ID: 2769391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies.
    Wikstrand CJ; Bigner SH; Bigner DD
    Cancer Res; 1983 Jul; 43(7):3327-34. PubMed ID: 6303581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The surface expression of a tumor-associated antigen on human kappa myeloma cells.
    Boux HA; Raison RL; Walker KZ; Musgrove E; Basten A
    Eur J Immunol; 1984 Mar; 14(3):216-22. PubMed ID: 6423392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated antigen defined by a monoclonal antibody against neuraminidase-treated human cancer cells.
    Ogasawara M; Takebe T; Ishii K
    Cancer Res; 1988 Jan; 48(2):412-7. PubMed ID: 3422053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
    Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
    Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody-dependent, cell-mediated cytotoxicity against human malignant gliomas.
    Takahashi H; Belser PH; Atkinson BF; Sela BA; Ross AH; Biegel J; Emanuel B; Sutton L; Koprowski H; Herlyn D
    Neurosurgery; 1990 Jul; 27(1):97-102. PubMed ID: 1695996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance for neurobiology and neurooncology of antigens of malignant gliomas as defined by monoclonal antibodies.
    Vrionis FD; Wikstrand CJ; Bigner DD
    Ann N Y Acad Sci; 1988; 540():64-77. PubMed ID: 2462837
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of a differentiation-specific cell surface antigen on HL60 cells that is associated with proliferation.
    Todd MB; Malech HL
    Cancer Res; 1986 Jan; 46(1):113-8. PubMed ID: 3455664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calibration of fluorescence intensities to quantify antibody binding surface determinants of cell subpopulations by flow cytometry.
    Dux R; Kindler-Röhrborn A; Lennartz K; Rajewsky MF
    Cytometry; 1991; 12(5):422-8. PubMed ID: 1718671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique human B lymphocyte antigen defined by a monoclonal antibody.
    Meeker TC; Miller RA; Link MP; Bindl J; Warnke R; Levy R
    Hybridoma; 1984; 3(4):305-20. PubMed ID: 6441771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.